Acura Settles Shareholder Claims Over Acurox For $1.5M
Acura Pharmaceuticals Inc. on Monday agreed to pay $1.5 million to resolve a putative shareholder class action in Illinois federal court claiming the drugmaker misrepresented the chances that its flagship painkiller...To view the full article, register now.
Already a subscriber? Click here to view full article